Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Nina-Sophie Schmidt-Hegemann"'
Autor:
Simon KB Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, Michael Mix, Matthias Benndorf, Fabian Bamberg, Marcus R Makowski, Simon Kirste, Alexander Rühle, Jerome Nouvel, Tanja Sprave, Marco ME Vogel, Polina Galitsnaya, Juergen E Gschwend, Christian Gratzke, Christian Stief, Steffen Loeck, Alex Zwanenburg, Christian Trapp, Denise Bernhardt, Stephan G Nekolla, Minglun Li, Claus Belka, Stephanie E Combs, Matthias Eiber, Lena Unterrainer, Marcus Unterrainer, Peter Bartenstein, Anca L Grosu, Constantinos Zamboglou, Jan C Peeken
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Purpose To develop a CT-based radiomic signature to predict biochemical recurrence (BCR) in prostate cancer patients after sRT guided by positron-emission tomography targeting prostate-specific membrane antigen (PSMA-PET). Material and methods Consec
Autor:
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, Dinah Konnerth, Sebastian Marschner, Nina-Sophie Schmidt Hegemann, Claus Belka, Minglun Li
Publikováno v:
Strahlentherapie und Onkologie. 198:727-734
Purpose Due to improved imaging, oligometastatic prostate cancer (OMPC) is diagnosed more frequently. Growing evidence shows that patients with a limited number of metastases benefit from primary-directed radiotherapy (PDT) as well as from metastasis
Autor:
Simon K.B. Spohn, Cédric Draulans, Amar U. Kishan, Daniel Spratt, Ashley Ross, Tobias Maurer, Derya Tilki, Alejandro Berlin, Pierre Blanchard, Sean Collins, Peter Bronsert, Ronald Chen, Alan Dal Pra, Gert de Meerleer, Thomas Eade, Karin Haustermans, Tobias Hölscher, Stefan Höcht, Pirus Ghadjar, Elai Davicioni, Matthias Heck, Linda G.W. Kerkmeijer, Simon Kirste, Nikolaos Tselis, Phuoc T. Tran, Michael Pinkawa, Pascal Pommier, Constantinos Deltas, Nina-Sophie Schmidt-Hegemann, Thomas Wiegel, Thomas Zilli, Alison C. Tree, Xuefeng Qiu, Vedang Murthy, Jonathan I. Epstein, Christian Graztke, Xin Gao, Anca L. Grosu, Sophia C. Kamran, Constantinos Zamboglou
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, 116, 3, pp. 503-520
International Journal of Radiation Oncology, Biology, Physics, 116, 503-520
International Journal of Radiation Oncology, Biology, Physics, 116, 503-520
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after surgery, but less data exist for patients treated with definitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131f9463d2f6dae60f3d62c5a057b8e1
Autor:
Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, Nicolas Mottet, Karel Hinnen, Gert De Meerleer, Cesare Cozzarini, Philippe Maingon, Ann Henry, Martin Spahn, Philip Cornford, Claus Belka, Thomas Wiegel
Publikováno v:
Radiotherapy and Oncology. 183:109544
Autor:
Nina-Sophie Schmidt-Hegemann, Rieke von Bestenbostel, Chukwuka Eze, Mathias J. Zacherl, Minglun Li, Christian G. Stief, Christian Trapp, Paul Rogowski, Alexander Kretschmer, Harun Ilhan, Ute Ganswindt, Peter Bartenstein, Leonie Beyer, Marcus Unterrainer, Claus Belka
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:1417-1428
Purpose Nodal recurrent prostate cancer (PCa) represents a common state of disease, amenable to local therapy. PSMA-PET/CT detects PCa recurrence at low PSA levels. The aim of this study was to evaluate the outcome of PSMA-PET/CT-based salvage radiot
Autor:
Minglun Li, Yourong Fan, Christian Trapp, Nina Sophie Schmidt-Hegemann, Jing Ma, Alexander Buchner, Shun Lu, Bin Xu, Christian Stief, Xuanbin Wang, Cheng Zhou, Claus Belka, Paul Rogowski
Publikováno v:
Clinical and translational radiation oncology. 39
To evaluate the feasibility of subsequent elective nodal radiotherapy (ENRT) for nodal recurrences after previous radiotherapy with a defined planning approach for a gapless radiation field junction.Patients with 1) previous radiotherapy of prostate
Autor:
Chukwuka Eze, Nina Sophie Schmidt-Hegemann, Farkhad Manapov, Minglun Li, Maurice Dantes, Julian Guggenberger, Olarn Roengvoraphoj, Arteda Gjika, Claus Belka, Julian Taugner, Lukas Käsmann
Publikováno v:
Acta Oncologica. 60:1074-1078
Concurrent platinum-based chemoradiation (CRT) followed by consolidation PD-L1 inhibition with durvalumab is the standard of care for patients with inoperable stage III NSCLC [1]. However, in high-...
Autor:
Kristian Unger, Julia Hess, Vera Link, Alexander Buchner, Chukwuka Eze, Minglun Li, Christian Stief, Thomas Kirchner, Frederick Klauschen, Horst Zitzelsberger, Maximilian Niyazi, Ute Ganswindt, Nina-Sophie Schmidt-Hegemann, Claus Belka
Publikováno v:
Clinical and Translational Radiation Oncology. 39:100586
Autor:
Lino M Sawicki, Olarn Roengvoraphoj, Julian Kirchner, Lukas Käsmann, Amanda Tufman, Marcus Unterrainer, Claus Belka, Nina-Sophie Schmidt-Hegemann, Jens Ricke, Farkhad Manapov, Julien Dinkel, Wolfgang G. Kunz, Chukwuka Eze, Lena M. Mittlmeier
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative review on the role of 18F-fluorodeoxyglucose positron emission tomogra
Autor:
Simon K. B. Spohn, Andrea Farolfi, Sarah Schandeler, Marco M. E. Vogel, Juri Ruf, Michael Mix, Simon Kirste, Francesco Ceci, Stefano Fanti, Helena Lanzafame, Francesca Serani, Christian Gratzke, August Sigle, Stephanie E. Combs, Denise Bernhardt, Juergen E. Gschwend, Josef A. Buchner, Christian Trapp, Claus Belka, Peter Bartenstein, Lena Unterrainer, Marcus Unterrainer, Matthias Eiber, Stephan G. Nekolla, Kilian Schiller, Anca L. Grosu, Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Jan C. Peeken
Publikováno v:
Eur. J. Nucl. Med. Mol. Imaging 50, 218-227 (2022)
Purpose This study aims to evaluate the association of the maximum standardized uptake value (SUVmax) in positron-emission tomography targeting prostate-specific membrane antigen (PSMA-PET) prior to salvage radiotherapy (sRT) on biochemical recurrenc